1. Home
  2. HUMAW vs LWAY Comparison

HUMAW vs LWAY Comparison

Compare HUMAW & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMAW
  • LWAY
  • Stock Information
  • Founded
  • HUMAW 2004
  • LWAY 1986
  • Country
  • HUMAW United States
  • LWAY United States
  • Employees
  • HUMAW 220
  • LWAY N/A
  • Industry
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • LWAY Packaged Foods
  • Sector
  • HUMAW Health Care
  • LWAY Consumer Staples
  • Exchange
  • HUMAW Nasdaq
  • LWAY Nasdaq
  • Market Cap
  • HUMAW N/A
  • LWAY N/A
  • IPO Year
  • HUMAW N/A
  • LWAY 1987
  • Fundamental
  • Price
  • HUMAW $0.49
  • LWAY $22.64
  • Analyst Decision
  • HUMAW
  • LWAY Hold
  • Analyst Count
  • HUMAW 0
  • LWAY 1
  • Target Price
  • HUMAW N/A
  • LWAY N/A
  • AVG Volume (30 Days)
  • HUMAW 14.2K
  • LWAY 46.0K
  • Earning Date
  • HUMAW 03-21-2025
  • LWAY 05-13-2025
  • Dividend Yield
  • HUMAW N/A
  • LWAY N/A
  • EPS Growth
  • HUMAW N/A
  • LWAY N/A
  • EPS
  • HUMAW N/A
  • LWAY 0.67
  • Revenue
  • HUMAW N/A
  • LWAY $188,277,000.00
  • Revenue This Year
  • HUMAW N/A
  • LWAY $14.93
  • Revenue Next Year
  • HUMAW N/A
  • LWAY $10.21
  • P/E Ratio
  • HUMAW N/A
  • LWAY $33.74
  • Revenue Growth
  • HUMAW N/A
  • LWAY 12.84
  • 52 Week Low
  • HUMAW $1.18
  • LWAY $10.06
  • 52 Week High
  • HUMAW $1.34
  • LWAY $27.29
  • Technical
  • Relative Strength Index (RSI)
  • HUMAW N/A
  • LWAY 42.57
  • Support Level
  • HUMAW N/A
  • LWAY $21.06
  • Resistance Level
  • HUMAW N/A
  • LWAY $25.54
  • Average True Range (ATR)
  • HUMAW 0.00
  • LWAY 0.91
  • MACD
  • HUMAW 0.00
  • LWAY -0.15
  • Stochastic Oscillator
  • HUMAW 0.00
  • LWAY 35.27

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: